Med-IQ
Collaborative Care for Depression and Comorbid Medical Conditions

Collaborative Care for Depression and Comorbid Medical Conditions

Med-IQ Express
Online Course | Specialties: Family Medicine, Internal Medicine, Primary Care, Psychiatry
Released: 6/7/2021
|
Expires: 6/6/2022
|
Max Credits: 0.5
Jump to Education

Faculty
Gary R. Maslow, MD
Associate Professor of Psychiatry and Behavioral Sciences
Co-Director of Child and Family Mental Health and Developmental Neurosciences
Associate Professor of Pediatrics
Assistant Professor in the School of Nursing
Duke University School of Medicine
Durham, NC
 
Activity Planners
Amy Burdette, PhD
Manager, Educational Strategy & Content
Med-IQ
Baltimore, MD

Jane Frutchey, MS
Managing Editor
Med-IQ
Baltimore, MD

Samantha Gordon, MS
Accreditation Manager
Med-IQ
Baltimore, MD

Amy Sison
Director of CME
Med-IQ
Baltimore, MD

Writer
Debra Gordon, MS
Highland Park, IL  
 
Learning Objective
Upon completion, participants should be able to:

  • Explore the collaborative care approach, including its core components, evidence base, and strategies to integrate the model into practice for the treatment of depression and comorbid medical conditions 

Target Audience
This activity is intended for primary care physicians, pediatricians, psychiatrists, neurologists, and psychiatry-focused nurse practitioners and physician assistants.
 
Statement of Need
In recent years, nearly 1 in 5 adults, or 51.5 million, lived with a mental health illness in the United States (US), yet only about one-half received mental health treatment. Depression is one of the most common comorbid conditions that occurs with physical illnesses such as cancer, cardiovascular disease, and metabolic, autoimmune, and neurologic conditions. The presence of depression significantly complicates the management of comorbid conditions, resulting in high overall healthcare costs and poor patient outcomes. There has been a shift in reimbursement models from volume-based care to value-based reimbursement, including in the realm of behavioral and mental health, which has faced challenges in delivering quality-based care. Given the cost and prevalence of the disease, depression outcomes are now a part of the value-based landscape and tied to performance measures.

To improve the quality of behavioral healthcare, collaborating with providers and coordinating care, delivering more patient-centered care, developing and reporting quality measures for behavioral health, and improving information technology were recommended and became the foundation of the collaborative care model (CCM). Studies have found that the CCM improves the quality of care delivered while increasing patient satisfaction and medication adherence. The CCM is a useful pathway to effectively manage and improve depression and comorbid health conditions while lowering healthcare costs and improving patient outcomes.

Collaborator Statement
This activity was developed by Med-IQ in collaboration with Duke Health.
Med-IQ      Duke Medicine

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Med-IQ designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Medium/Method of Participation
This CE activity consists of a 0.5-credit online publication. To receive credit, read the introductory CE material, read the publication, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.  
 
Initial Release Date: June 7, 2021
Expiration Date: June 6, 2022
Estimated Time to Complete This Activity: 30 minutes

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 24 months that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 

Debra Gordon, MS
Ownership interest (stocks/stock options – excluding mutual funds): AbbVie, Merck & Co., Inc.

Gary R. Maslow, MD
Contracted research: Pfizer, Inc.

The peer reviewers and other activity planners have no financial relationships to disclose. 
 
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
 
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
 
Contact Information        
For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email info@med-iq.com.

System Requirements

Desktop

Mobile

  • Operating system - Med-IQ supports the current operating system, plus two prior releases:
    • Android (eg, Samsung Galaxy)
    • Apple (eg, iPhone/iPad)
  • Browsers - Med-IQ supports the default browser for the applicable operating system release, plus two prior releases:
    • Android (Chrome)
    • Apple (Safari)

Applications & Software

For technical assistance, please refer to our Support Manual.

Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.med-iq.com/privacy-statement/.
 
Complimentary CME
This activity is available free of charge to participants.

Copyright
© 2021 Duke University Health System

Abstract

Here are the key takeaways from this activity. Deeper insights and evidence, plus an opportunity to receive credit, are available at the "Continue" button below.

  • Depression is a common mental health condition and often occurs with comorbid physical illnesses such as cancer, cardiovascular disease, and metabolic, autoimmune, and neurologic conditions
  • Healthcare reimbursement is transitioning from that of volume- to value-based care, including in the realm of behavioral and mental health, which has faced challenges in delivering quality-based care
  • Given the cost and prevalence of the disease, depression outcomes are now a part of the value-based landscape and tied to performance measures
  • Studies have found that the CCM enhances the quality of care delivered while increasing patient satisfaction and medication adherence, as well as improves chronic health conditions and depression
  • CCM represents a useful pathway to effectively manage depression and comorbid conditions while lowering healthcare costs and improving treatment access and patient outcomes

View reference list.

Click “Continue” to proceed through this activity and/or receive credit.

By clicking "Continue," you confirm that you have reviewed the CME information.

Continue

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

COPYRIGHTED. Republication or redistribution of Med‑IQ content, including by framing, is prohibited without prior written consent. Med‑IQ shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.